Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renu Dhanasekaran

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinics in Liver Disease|October 9, 2017
The Liver in OncologyRenu Dhanasekaran, Paul Y Kwo
World Journal of Hepatology|October 11, 2021
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challengeÂngelo Z Mattos, Jose D Debes, Renu Dhanasekaran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 2, 2023
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortiumBrahma Natarajan, Parissa Tabrizian, Maarouf Hoteit, et al.
Kidney International Reports|September 22, 2025
The Immune Microenvironment of Transplant GlomerulitisNathan A Bracey, Jonathan S Maltzman, Adrienne H Long, et al.
Human Pathology|September 30, 2021
Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classificationMichael Torbenson, Chantal E McCabe, Daniel R O'Brien, et al.
Gastroenterology|July 31, 2021
Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) ConsortiumNeil Mehta, Catherine Frenette, Parissa Tabrizian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinics in Liver Disease|October 9, 2017
The Liver in OncologyRenu Dhanasekaran, Paul Y Kwo
World Journal of Hepatology|October 11, 2021
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challengeÂngelo Z Mattos, Jose D Debes, Renu Dhanasekaran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 2, 2023
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortiumBrahma Natarajan, Parissa Tabrizian, Maarouf Hoteit, et al.
Kidney International Reports|September 22, 2025
The Immune Microenvironment of Transplant GlomerulitisNathan A Bracey, Jonathan S Maltzman, Adrienne H Long, et al.
Human Pathology|September 30, 2021
Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classificationMichael Torbenson, Chantal E McCabe, Daniel R O'Brien, et al.
Gastroenterology|July 31, 2021
Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) ConsortiumNeil Mehta, Catherine Frenette, Parissa Tabrizian, et al.
Pageof 1